CHAD65 and CHA2DS2-VASc risk stratification tools for patients with atrial fibrillation : a review of clinical effectiveness and guidelines /
The purpose of this report is to review the clinical effectiveness of the CHAD65 and CHA2DS2-VASc risk stratification tools compared to each other or to CHADS2 to determine the need for pharmacological treatment in patients with atrial fibrillation (AF). Additionally, this report aims to review evid...
Saved in:
| Online Access: |
http://www.ncbi.nlm.nih.gov/books/NBK525846/ Full text |
|---|---|
| Main Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Ottawa (ON) :
Canadian Agency for Drugs and Technologies in Health,
2017
|
| Series: | Rapid response report (Canadian Agency for Drugs and Technologies in Health)
|
| Subjects: |
